AZN•benzinga•
AstraZeneca Announced Imfinzi Plus Chemotherapy Granted Priority Review in the Us for Patients With Locally Advanced or Metastatic Biliary Tract Cancer Based on TOPAZ-1 Phase III Trial
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 4, 2022 by benzinga